This single-centre prospective study included 1,490 patients who had symptoms suggestive of ACS but without an ST elevation on the initial ECG. AI-based ECG interpretation ruled out occlusive MI in 1, ...
11d
HeartBeam (NASDAQ: BEAT) Outlines Regulatory Strategy After NSE Decision on ECG Synthesis Software
HeartBeam (NASDAQ: BEAT), a medical technology company developing personalized cardiac-care insights, detailed its ...
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results